Efficacy and safety of fingolimod versus glatiramer acetate in patients with relapsing-remitting multiple sclerosis in the ASSESS study

The requested reference [4d9455c721fd9cb6486327aec4786cc3c3892a15] no longer exists in our database. It has been replaced by the current reference: [859c1b7af05780fbed261081ba652f21be95df54]

Authors
Category Primary study
Journal2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers
Year 2019
This article has no abstract
Epistemonikos ID: 351dcd2c4355460303ece494a6e318fdd9831000
First added on: Dec 18, 2021